Giacomini, K.M., Gibson, T.P. & Levy, G. (1978). Plasma protein binding of d-propoxyphene in normal subjects and anephric patients. J. Clin. Pharmacol., 18, 106-107.
2.
Giacomini, K.M., Giacomini, J.C., Gibson, T.P. & Levy, G. (1980). Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed postcaval shunt. Clin. Pharmacol. Ther., 28, 417-424.
3.
Gibson, T.P., Giacomini, K.M., Briggs, W.A., Whitman, W. & Levy, G. (1980). Propoxyphene and norpropoxyphene concentrations in the anephric patient. Clin. Pharmacol. Ther., 27, 665-670.
4.
Glab, W.N., Corby, D.G., Decker, W.J. & Coldiron, V.R. (1982). Decreased absorption of propoxyphene by activated charcoal. J. Toxicol. Clin. Toxicol. , 19, 129-138.
5.
Gram, C.F., SCHOU, J., WAY, W. L., HELTBERG, J. & BODIN, N. O. (1979). d-Propoxyphene kinetics after single oral and intravenous doses in man. Clin. Pharmacol. Ther., 26,473-482.
6.
Inturrisi, C.E., Colburn, W.A., Verebely, K., Dayton, H.E., Woody, G.E. & O'Brien, C.P. (1982). Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene. Clin. Pharmacol. Ther., 31, 157-167.
7.
McMahon, R.E., Ridolfo, A.S., Culp, H.W., Wolen, R.L. & Marshall, F.J. (1971). Fate of radiocarbon-labelled propoxyphene in rat, dog and human. Toxicol. Appl. Pharmacol. , 19,427-444.
8.
Perrier, D. & Gibaldi, M. (1972). Influence of first-pass effect on the systemic availability of propoxyphene. J. Clin. Pharmacol., 12, 449-452.
9.
Rodda, B.E., Scholz, N.E., Gruber, C.M. & Wolen, R.L. (1971). Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principle component - analysis of variance technique. Case 1 - Equimolar doses. Toxicol. Appl. Pharmacol., 19, 554-562.
10.
Schou, J., Angelo, H., Dann, W., Jenssen, K. & Christansen, J.M. (1978). Pharmacokinetics of dextropropoxyphene in acute poisoning. Arch. Toxicol. (Suppl. 1), 343-346.
11.
Swanson, B.N., Gibson, W.P., Lynn, R.K. & Gerber, N. (1978). Seminal excretion, vaginal absorption, distribution and whole blood kinetics of d-methadone in the rabbit. J. Pharmacol. Exp. Ther., 206, 507-514.
12.
Verebely, K. & Inturrisi, C.E. (1974). Disposition of propoxyphene and norpropoxyphene in man after a single dose. Clin. Pharmacol. Ther., 15, 302-309.
13.
Way, W.L. & Schou, J. (1979). Entrance into brain of dextropropoxyphene and the toxic metabolite norpropoxyphene. Arch. Toxicol. (Suppl. 2), 367-370.
14.
Welling, P.G., LYONS, L. L., TEE, M. S. & CRAIG, W. A. (1976). Propoxyphene and norpropoxyphene: influence of diet and fluid on plasma levels. Clin. Pharmacol. Ther., 19, 559-565.
15.
Wilson, S.T., Atwood, G.F. & Shand, D.G. (1976). Disposition of propoxyphene and propranolol in children. Clin. Pharmacol. Ther., 19, 264-270.
16.
Wolen, R.L., Gruber, C.M., Kiplinger, G.F. & Scholz, N.E. (1971). Concentration of propoxyphene in human plasma following oral, intramuscular and intravenous administration. Toxicol. Appl. Pharmacol., 19, 480-492.
17.
Zaman, S., Pearson, R.M., Lamb, J.M. & Esberger, D.A. (1984). Inhibition of sperm motility by opiate drugs. Br. J. Clin. Pharmacol. (Proceedings Suppl.), 82, in press.
